Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced ...

Cediranib maleate is under clinical development by AstraZeneca and currently in Phase II for Small-Cell Lung Cancer.

Cediranib maleate is under clinical development by AstraZeneca and currently in Phase II for Triple-Negative Breast Cancer (TNBC).

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

A Kingston, Ont., resident says he's finally getting the treatment he needs for a rare cancer he was diagnosed with since the ...

At the time of writing this, I am 22 years old and I haven’t had penetrative sex in two years. It seems that the recurrent ...

Rowan's parents are campaigning to make genetic testing part of routine screening during pregnancy after their baby boy died ...

Aileron’s lead product candidate, LTI-03, is a novel, synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. Currently, LTI ...

Cows may serve as a potential host for influenza A virus, with implications for zoonotic transmission to humans.

Naturally I felt very relieved to have a diagnosis, but I was annoyed to have yet another medical condition to deal with. I ...

LTI-03 reduced tissue scarring-promoting protein levels in the first group of IPF patients participating in a Phase 1b trial, ...